Attached files
| file | filename |
|---|---|
| EX-32 - EXHIBIT 32 - Lineage Cell Therapeutics, Inc. | ex32.htm |
| EX-31 - EXHIBIT 31 - Lineage Cell Therapeutics, Inc. | ex31.htm |
| 10-K - BIOTIME 10-K 12-31-2009 - Lineage Cell Therapeutics, Inc. | form10k.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby
consent to the incorporation by reference in the Registration Statements on Form
S-3 (No. 333-99205) and Form S-8 (Nos. 33-56766, 33-88968, 333-101651,
333-122844, 333-163396) of BioTime, Inc. of: (i) our report dated February 11,
2010, with respect to the audit of the consolidated balance sheets of BioTime,
Inc. as of December 31, 2009 and 2008, and the related consolidated statements
of operations, changes in stockholders' equity, and cash flows for the two years
then ended, which report appears in the Annual Report on Form 10-K of BioTime,
Inc. for the year ended December 31, 2009; and (ii) to the reference to our firm
under the heading “Experts” in the prospectus.
/s/
ROTHSTEIN KASS & COMPANY, P.C.
Roseland,
New Jersey
February
16, 2010